Golden Meditech Holdings Limited reported unaudited consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported revenue from continuing operations of HKD 121,672,000 compared to HKD 150,527,000 a year ago. Loss from operations was HKD 162,014,000 compared to HKD 116,621,000 a year ago. Loss before taxation was HKD 325,548,000 compared to HKD 146,271,000 a year ago. Loss for the period from continuing operations was HKD 329,428,000 compared to HKD 150,813,000 a year ago. Loss for the period was HKD 193,947,000 compared to HKD 380,153,000 a year ago. Loss attributable to the company's equity shareholders from continuing operations was HKD 317,154,000 or 10.69 cents per basic share compared to HKD 138,275,000 or 7.36 cents per basic share a year ago. Net cash generated from investing activities was HKD 246,291,000 compared to HKD 49,267,000 a year ago. Payment for purchase of property, plant and equipment was HKD 44,183,000 compared to HKD 85,637,000 a year ago. Loss before interest, tax, depreciation and amortisation, fair value changes in financial assets and financial liabilities was HKD 113,082,000 compared to HKD 74,132,000 a year ago. Adjusted loss attributable to the company's equity shareholders was HKD 166,752,000 or 5.62 cents per basic share compared to HKD 138,275,000 or 7.36 cents per basic share a year ago.